Market Overview:
The global intraoperative fluorescence systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for minimally invasive surgeries and technological advancements in intraoperative fluorescence systems. The global intraoperative fluorescence systems market is segmented by type, application, and region. By type, the market is divided into automated cell imaging system, in vivo imaging system, and high-content imaging system. The automated cell imaging system segment is expected to grow at the highest CAGR during the forecast period owing to its ability to provide fast and accurate results. By application, the hospital segment dominates the global intraoperative fluorescence systems market due to rising number of minimally invasive surgeries being performed in hospitals globally.
Product Definition:
Intraoperative fluorescence systems are medical devices that use light to detect and identify cancer cells during surgery. The devices work by emitting a specific wavelength of light that causes cancer cells to glow. This allows surgeons to easily identify and remove any cancerous tissue while performing surgery. Intraoperative fluorescence systems are important because they help improve the accuracy of tumor removal, which can lead to improved patient outcomes.
Automated Cell Imaging System:
Automated cell imaging system is a tool that helps in visualizing and analyzing the cells under a microscope. It provides high-resolution images of living tissues or cells with the help of fluorescent dyes. The intraoperative fluorescence systems market is expected to witness significant growth over the forecast period owing to factors such as increasing demand for minimally invasive surgeries, growing prevalence of chronic diseases, technological advancements in medical imaging and increasing government initiatives.
In Vivo Imaging System:
In vivo imaging system is a medical device that records the physiological and molecular processes of living organisms, for instance, in the intact animal or human body. The images captured by these devices are used to study disease progression at a cellular level.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to increasing demand for advanced surgical procedures that require intraoperative fluorescence imaging systems. Increasing number of hospitals and surgeries are driving the growth of this segment. Moreover, a rise in healthcare spending by governments as well as private organizations is fueling growth across various regions globally. This factor will further boost demand over the forecast period (2018-2030).
The other application includes research laboratories or educational institutions where these devices are used for teaching purposes or diagnostic training sessions conducted by medical professionals such as surgeons, anesthesiologists and intensivists among others. Intraoperative fluorescence allows users to see structures more clearly during surgery which aids them in delivering precise intracorporal doses of anesthetic agents thus making it suitable for use in educational settings where students undergo training with regards to surgical procedures being performed by medical professionals (intensivists).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players and high adoption rate for technologically advanced products. The region is expected to maintain its dominance over the forecast period due to increasing government funding for research and development activities, rise in healthcare expenditure, and growing awareness about intraoperative fluorescence imaging systems. Moreover, increasing cases of cancer are also driving demand for IOFIS-based procedures across North America.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising healthcare expenditure by governments as well as private agencies in order to improve patient care standards & facilities across emerging countries such as China & India. In addition, these countries have adopted western culture resulting into higher adoption rates for innovative medical devices including intraoperative fluorescence imaging systems in recent years (last 5 years).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The Intraoperative Fluorescence Systems market is expected to benefit from the increasing demand for minimally invasive surgeries. This is because these systems help surgeons to visualize tissues and organs more clearly, which makes it easier to carry out procedures with minimal damage.
- Growing awareness about the benefits of fluorescence-guided surgery: There is a growing awareness among surgeons and patients about the benefits of fluorescence-guided surgery. This is helping to drive demand for Intraoperative Fluorescence Systems products.
- Technological advancements: The Intraoperative Fluorescence Systems market is benefiting from ongoing technological advancements that are making these systems more efficient and user-friendly. For instance, recent advances in LED technology are helping to improve image quality and reduce surgical timeframes.
- Rising incidence of cancer: The incidence of cancer is on the rise globally, which is leading to an increase in the number of surgeries being carried out each year. This will create opportunities for players in the Intraoperative Fluorescence Systems market over the forecast period . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Intraoperative Fluorescence Systems Market Research Report
By Type
Automated Cell Imaging System, In Vivo Imaging System, High-content Imaging System
By Application
Hospital, Clinic, Other
By Companies
GE, Philips, Carl Zeiss Meditec, Siemens, Epic Systems, Miltenyi Biotec, Molecular Devices, Berthold Bioanalytic, Nikon, HORIBA Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Intraoperative Fluorescence Systems Market Report Segments:
The global Intraoperative Fluorescence Systems market is segmented on the basis of:
Types
Automated Cell Imaging System, In Vivo Imaging System, High-content Imaging System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE
- Philips
- Carl Zeiss Meditec
- Siemens
- Epic Systems
- Miltenyi Biotec
- Molecular Devices
- Berthold Bioanalytic
- Nikon
- HORIBA Scientific
Highlights of The Intraoperative Fluorescence Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automated Cell Imaging System
- In Vivo Imaging System
- High-content Imaging System
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intraoperative Fluorescence Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intraoperative fluorescence systems are a type of medical imaging technology that uses fluorescent dyes to image internal organs and tissues during surgery. These systems can help surgeons see details inside the body that they would otherwise miss, and can also help them track the progress of surgeries.
Some of the key players operating in the intraoperative fluorescence systems market are GE, Philips, Carl Zeiss Meditec, Siemens, Epic Systems, Miltenyi Biotec, Molecular Devices, Berthold Bioanalytic, Nikon, HORIBA Scientific.
The intraoperative fluorescence systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intraoperative Fluorescence Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intraoperative Fluorescence Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intraoperative Fluorescence Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intraoperative Fluorescence Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intraoperative Fluorescence Systems Market Size & Forecast, 2020-2028
4.5.1 Intraoperative Fluorescence Systems Market Size and Y-o-Y Growth
4.5.2 Intraoperative Fluorescence Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Automated Cell Imaging System
5.2.2 In Vivo Imaging System
5.2.3 High-content Imaging System
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intraoperative Fluorescence Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intraoperative Fluorescence Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Automated Cell Imaging System
9.6.2 In Vivo Imaging System
9.6.3 High-content Imaging System
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Automated Cell Imaging System
10.6.2 In Vivo Imaging System
10.6.3 High-content Imaging System
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Automated Cell Imaging System
11.6.2 In Vivo Imaging System
11.6.3 High-content Imaging System
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Automated Cell Imaging System
12.6.2 In Vivo Imaging System
12.6.3 High-content Imaging System
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Automated Cell Imaging System
13.6.2 In Vivo Imaging System
13.6.3 High-content Imaging System
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intraoperative Fluorescence Systems Market: Competitive Dashboard
14.2 Global Intraoperative Fluorescence Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE
14.3.2 Philips
14.3.3 Carl Zeiss Meditec
14.3.4 Siemens
14.3.5 Epic Systems
14.3.6 Miltenyi Biotec
14.3.7 Molecular Devices
14.3.8 Berthold Bioanalytic
14.3.9 Nikon
14.3.10 HORIBA Scientific
